FDA Inspection 1070321 — Dendreon Pharmaceuticals LLC

Dendreon Pharmaceuticals LLC — FEI 3008914686

The FDA completed an inspection of Dendreon Pharmaceuticals LLC on Oct 22, 2018 in Union City, GA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Oct 22, 2018
Fiscal Year
2019
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Union City, GA (United States)

Citations

IDCFRDescription
7821 CFR 606.100(c)Record review prior to release
93221 CFR 123.7(d)Corrective action documentation

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.